• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[3H]AL - 5848([3H]9β-(+)-氟前列醇)。曲伏前列素(AL - 6221)的羧酸,一种用于研究FP受体药理学和放射自显影定位的新型FP前列腺素。

[3H]AL-5848 ([3H]9beta-(+)-Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor.

作者信息

Sharif N A, Davis T L, Williams G W

机构信息

Molecular Pharmacology Unit, Alcon Laboratories, Inc., Fort Worth, TX 76134-2099, USA.

出版信息

J Pharm Pharmacol. 1999 Jun;51(6):685-94. doi: 10.1211/0022357991772989.

DOI:10.1211/0022357991772989
PMID:10454045
Abstract

AL-5848 (5Z,13E)-(9 S,11R,15S)-9,11,15-trihydroxy-5,13-prostadienoic acid) is the carboxylic acid of travoprost (AL-6221), a single (+)-isomer of (+/-)-fluprostenol, an FP-class prostaglandin agonist which lowers intraocular pressure. We have prepared a radioligand from this selective prostaglandin and demonstrated its utility for studying the pharmacology and autoradiographic location of the FP-receptor. Specific [3H]AL-5848 binding (84% of total) was linearly related to bovine corpus luteum tissue concentration and reached equilibrium within 275 min at 23 degrees C. Scatchard analysis of saturation isotherms indicated interaction of [3H]AL-5848 with a single class of high-affinity (dissociation constant, Kd, = 33.8+/-2.9 nM, n = 4) and saturable (Bmax = 37.3+/-3.0 pmol (g wet weight tissue)(-1)) FP receptor-binding sites in bovine corpus luteum. Specific [3H]AL-5848 binding was potently inhibited by the FP-receptor ligands 16-phenoxyPGF2alpha (inhibition constant Ki = 17.3 nM); cloprostenol (Ki = 56.8 nM); 17-phenyl PGF2alpha (Ki = 87.0 nM); AL-5848 (Ki = 52.1 nM); PGF2alpha (Ki = 195 nM); PHXA85 (Ki = 223 nM); (n = 3-11) but very weakly by PGD2, ZK118182, BW245C, PGE2, PGI2 and U-46619. The pharmacology of specific [3H]AL-5848 binding correlated well with the pharmacology of [3H]PGF2alpha binding in the bovine corpus luteum preparation (r = 0.98, n = 14, P<0.0001) and also with functional responses in Swiss 3T3 and rat vascular smooth muscle cells (A7r5) (r = 0.96) expressing FP receptors. Autoradiographic studies revealed high levels of specific FP-receptor binding with [3H]AL-5848 on granulosa cells in the bovine corpus luteum sections, and on longitudinal ciliary muscle, the ciliary process, the iris sphincter and the retina in eye sections from man. These studies show [3H]AL-5848 to be a high-affinity agonist radioligand capable of selectively labelling the FP prostaglandin receptor.

摘要

AL-5848((5Z,13E)-(9S,11R,15S)-9,11,15-三羟基-5,13-前列腺二烯酸)是曲伏前列素(AL-6221)的羧酸,曲伏前列素是(+/-)-氟前列醇的单一(+)-异构体,一种能降低眼压的FP类前列腺素激动剂。我们从这种选择性前列腺素制备了一种放射性配体,并证明了其在研究FP受体的药理学和放射自显影定位方面的效用。特异性[3H]AL-5848结合(占总量的84%)与牛黄体组织浓度呈线性相关,在23℃下275分钟内达到平衡。对饱和等温线的Scatchard分析表明,[3H]AL-5848与牛黄体中一类单一的高亲和力(解离常数Kd = 33.8±2.9 nM,n = 4)且可饱和(Bmax = 37.3±3.0 pmol/(g湿重组织))的FP受体结合位点相互作用。FP受体配体16-苯氧基PGF2α(抑制常数Ki = 17.3 nM)、氯前列醇(Ki = 56.8 nM)、17-苯基PGF2α(Ki = 87.0 nM)、AL-5848(Ki = 52.1 nM)、PGF2α(Ki = 195 nM)、PHXA85(Ki = 223 nM)(n = 3 - 11)能有效抑制特异性[3H]AL-5848结合,但PGD2、ZK118182、BW245C、PGE2、PGI2和U-46619的抑制作用非常弱。特异性[3H]AL-5848结合的药理学与牛黄体制剂中[3H]PGF2α结合的药理学相关性良好(r = 0.98,n = 14,P<0.0001),也与表达FP受体的瑞士3T3和大鼠血管平滑肌细胞(A7r5)中的功能反应相关性良好(r = 0.96)。放射自显影研究显示,在牛黄体切片的颗粒细胞上,以及在人眼切片的纵行睫状肌、睫状体、虹膜括约肌和视网膜上,[3H]AL-5848有高水平的特异性FP受体结合。这些研究表明[3H]AL-5848是一种能够选择性标记FP前列腺素受体的高亲和力激动剂放射性配体。

相似文献

1
[3H]AL-5848 ([3H]9beta-(+)-Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor.[3H]AL - 5848([3H]9β-(+)-氟前列醇)。曲伏前列素(AL - 6221)的羧酸,一种用于研究FP受体药理学和放射自显影定位的新型FP前列腺素。
J Pharm Pharmacol. 1999 Jun;51(6):685-94. doi: 10.1211/0022357991772989.
2
Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.[3H]前列腺素E1/[3H]前列腺素E2以及[3H]前列腺素F2α与牛黄体中EP3和FP前列腺素受体结合位点的结合药理学:特性及其与功能数据的相关性
J Pharmacol Exp Ther. 1998 Aug;286(2):1094-102.
3
Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.眼内压降低的FP前列腺素(PG)类似物:PG受体亚型结合亲和力和选择性,以及在培养细胞中对FP和其他PG受体的激动剂效力。
J Ocul Pharmacol Ther. 2003 Dec;19(6):501-15. doi: 10.1089/108076803322660422.
4
Quantitative autoradiographic visualization and pharmacology of FP-prostaglandin receptors in human eyes using the novel phosphor-imaging technology.
J Ocul Pharmacol Ther. 1999 Aug;15(4):323-36. doi: 10.1089/jop.1999.15.323.
5
Bovine iris-sphincter muscle lacks FP receptor binding sites.
Ocul Immunol Inflamm. 1999 Mar;7(1):39-50. doi: 10.1076/ocii.7.1.39.8111.
6
AL-3138 antagonizes FP prostanoid receptor-mediated inositol phosphates generation: comparison with some purported FP antagonists.AL-3138拮抗前列腺素F受体介导的肌醇磷酸生成:与一些所谓的前列腺素F拮抗剂的比较。
J Pharm Pharmacol. 2000 Dec;52(12):1529-39. doi: 10.1211/0022357001777586.
7
Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.DP/EP2类前列腺素AL-6598的分子药理学及人眼DP和EP2受体位点的定量放射自显影可视化
J Ocul Pharmacol Ther. 2004 Dec;20(6):489-508. doi: 10.1089/jop.2004.20.489.
8
Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.比马前列素、曲伏前列素、拉坦前列素、异丙酸乌诺前列酮及其他前列腺素类似物在克隆的人睫状体FP前列腺素受体上的激动剂活性。
J Ocul Pharmacol Ther. 2002 Aug;18(4):313-24. doi: 10.1089/10807680260218489.
9
AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor.AL-8810:一种新型前列腺素F2α类似物,对前列腺素F2α(FP)受体具有选择性拮抗作用。
J Pharmacol Exp Ther. 1999 Sep;290(3):1278-84.
10
Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors.曲伏前列酸、比马前列素、乌诺前列酮及其他类似物通过内源性小鼠、大鼠和克隆的人FP前列腺素受体实现实时细胞内钙离子动员。
J Pharmacol Exp Ther. 2003 Jan;304(1):238-45. doi: 10.1124/jpet.102.042556.

引用本文的文献

1
Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma.前列腺素类似物在青光眼治疗中的临床药理学与药物遗传学
Front Pharmacol. 2022 Oct 12;13:1015338. doi: 10.3389/fphar.2022.1015338. eCollection 2022.
2
Neuroaxonal and cellular damage/protection by prostanoid receptor ligands, fatty acid derivatives and associated enzyme inhibitors.前列腺素受体配体、脂肪酸衍生物及相关酶抑制剂对神经轴突和细胞的损伤/保护作用
Neural Regen Res. 2023 Jan;18(1):5-17. doi: 10.4103/1673-5374.343887.
3
Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies.
治疗高眼压症和青光眼的治疗药物与设备,以及神经保护和细胞保护疗法的必要性。
Front Pharmacol. 2021 Sep 17;12:729249. doi: 10.3389/fphar.2021.729249. eCollection 2021.
4
Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.抗过敏(依美斯汀;帕坦洛/帕迪特/帕泽奥)和抗青光眼(曲伏前列素;辛布林扎)眼科药物的研发至上市,以及新型药理学工具如AL - 8810的产生。
ACS Pharmacol Transl Sci. 2020 Nov 5;3(6):1391-1421. doi: 10.1021/acsptsci.0c00137. eCollection 2020 Dec 11.
5
Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility.前列腺素 FP 受体拮抗剂:发现、药理学特性和治疗用途。
Br J Pharmacol. 2019 Apr;176(8):1059-1078. doi: 10.1111/bph.14335. Epub 2018 Jun 7.
6
Effects of prostaglandin analogues on aqueous humor outflow pathways.前列腺素类似物对房水流出途径的影响。
J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):102-9. doi: 10.1089/jop.2013.0179. Epub 2013 Dec 20.
7
Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis.前列腺素F2α会升高血压并促进动脉粥样硬化。
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7985-90. doi: 10.1073/pnas.0811834106. Epub 2009 Apr 24.
8
Travoprost.曲伏前列素
Drugs Aging. 2002;19(6):465-71; discussion 472-3. doi: 10.2165/00002512-200219060-00005.
9
Pharmacology and autoradiography of human DP prostanoid receptors using [(3)H]-BWA868C, a DP receptor-selective antagonist radioligand.使用DP受体选择性拮抗剂放射性配体[(3)H]-BWA868C对人DP前列腺素受体进行的药理学与放射自显影研究
Br J Pharmacol. 2000 Nov;131(6):1025-38. doi: 10.1038/sj.bjp.0703686.
10
Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor.[(3)H]-前列腺素E(2)与克隆的人EP(4)类前列腺素受体结合的药理学特性
Br J Pharmacol. 2000 Aug;130(8):1919-26. doi: 10.1038/sj.bjp.0703525.